SIREN : 807704457
CONSILIUM SANTE is a French company founded 11 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in DENICE (69640), this company of category PME shows in 2024 a revenue of 115 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 |
|---|---|---|
| Revenue | 114 753 € | 116 099 € |
| Net income | 119 537 € | 308 549 € |
| EBITDA | 85 812 € | 80 532 € |
| Net margin | 104.2% | 265.8% |
In 2024, CONSILIUM SANTE achieves revenue of 115 k€. Slight decline of -1% vs 2023. After deducting consumption (0 €), gross margin stands at 115 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 86 k€, representing 74.8% of revenue. Positive scissor effect: EBITDA margin improves by +5.4 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 120 k€, i.e. 104.2% of revenue. This profit can be retained or distributed to shareholders.
114 753 €
114 753 €
85 812 €
75 528 €
119 537 €
74.8%
The debt ratio (= Financial debt / Equity x 100) stands at 33%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 113.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
33.179%
22.17%
113.683%
1.501
63.6%
In 2024, the debt ratio of CONSILIUM SANTE (33.18) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of CONSILIUM SANTE (22.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of CONSILIUM SANTE (1.50) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 81.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 236.4x. Operating income very largely covers interest expenses: high safety margin.
81.276
236.442
In 2024, the liquidity ratio of CONSILIUM SANTE (81.28) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of CONSILIUM SANTE (236.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 153 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 112 days. The gap of 41 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. WCR is negative (-158 days): operations structurally generate cash.
-50 212 €
153 j
112 j
0 j
-158 j
Based on 69 transactions of similar company sales
in 2024,
the value of CONSILIUM SANTE is estimated at
370 962 €
(range 112 041€ - 732 073€).
With an EBITDA of 85 812€, the sector multiple of 4.3x is applied.
The price/revenue ratio is 0.66x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare CONSILIUM SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion
The revenue of CONSILIUM SANTE in 2024 is 115 k€.
Yes, CONSILIUM SANTE generated a net profit of 120 k€ in 2024.
The headquarters of CONSILIUM SANTE is located in DENICE (69640), in the department Rhone.
The tax return of CONSILIUM SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CONSILIUM SANTE operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.